Founded in 2012, Beijing Biosis Healing Biological Technology Co.,Ltd has been engaged in providing innovative and comprehensive SIS biological materials for the whole surgery for the tissue repair and regeneration. Based on the SIS core technology, a series of implantable SIS material for tissue repair have been developed, covering a number of important surgical fields such as cardiac surgery, vascular surgery, gastrointestinal surgery, abdominal surgery, anorectal surgery, thoracic surgery, neurosurgery, orthopedics, oral and maxillofacial surgery etc. Several products were obtained CE and FDA approval in 2022.
The company insists on technological innovation as its core competitiveness, and has been awarded as national high-tech enterprise, post-doctoral research center , technology R&D institution of Beijing and Zhongguancun high-tech enterprise. Undertake a number of provincial and ministerial-level R&D projects, the company's R&D center has received funding from the National Development and Reform Commission's Biomedicine Public Service Platform Project, and the research results of biomaterials have been included in the representative achievements of Zhongguancun 40th year biomedical innovation. The non-crosslinked extracellular matrix derived biomaterials (SIS materials) was listed part of the National Key R&D Program (The No. 863) in the new material project of the Ministry of Science and Technology, with a funding from National Development and Reform Commission for innovation projects. The Staple line reinforcement patch was listed as innovative priority approval products from the National Medical Products Administration.
In the future, Biosis Healing will continue to take "innovation, research and development" as the foundation of the company, and will be committed to providing advanced and comprehensive solutions for the whole surgeries. By promoting surgical clinical innovation, Biosis Healing will make unremitting efforts to deliver high-quality medical products and services to benefit more patients. Make unremitting efforts to improve the quality of human lives.
Several products obtained the certificates in 2022 Dental matrix and staple line reinforcement got NMPA approval 5pcs surgical staplers have got US FDA (510K)
PPE products export in 2020 The establishment of No.1 biomedical public service platform Export the PPE products into 24 countries over 1 billion
SIS hernia Patch got CFDA priority approval in 2018; Obtained Beijing S&T process progress Award
National High-Tech Enterprise in 2016
Beijing Patent Pilot Enterprise in 2014
Company Founded in the No.1 Medicine Valley in 2012
National Professional Special Innovative “Small Giant” Enterprise in 2021 Biological SIS hernia graft has got CE ; Biological Anal fistula plug and Dural repair patch got NMPA approval
Wu Jieping Medical Foundation--Biosis healing Excellent Surgery Special Fund Project in 2019
77 authorized Chinese inventional patents; 14 authorized international inventional patents ;
Undertaking the National Key R&D Program (The No. 863) in the new material project
Obtained a fund for innovation projects as a technology-based enterprise
Several products obtained the certificates in 2022 Dental matrix and staple line reinforcement got NMPA approval 5pcs surgical staplers have got US FDA (510K)
National Professional Special Innovative “Small Giant” Enterprise in 2021 Biological SIS hernia graft has got CE ; Biological Anal fistula plug and Dural repair patch got NMPA approval
PPE products export in 2020 The establishment of No.1 biomedical public service platform Export the PPE products into 24 countries over 1 billion
Wu Jieping Medical Foundation--Biosis healing Excellent Surgery Special Fund Project in 2019
SIS hernia Patch got CFDA priority approval in 2018; Obtained Beijing S&T process progress Award
77 authorized Chinese inventional patents; 14 authorized international inventional patents ;
National High-Tech Enterprise in 2016
Undertaking the National Key R&D Program (The No. 863) in the new material project
Beijing Patent Pilot Enterprise in 2014
Obtained a fund for innovation projects as a technology-based enterprise
Company Founded in the No.1 Medicine Valley in 2012
版权所有®2019BIOSISHEALING